The orexin receptor antagonist lemborexant (Dayvigo) has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults, Eisai Co. announced.
Soldiers who have insomnia before deployment may be more likely to develop post-traumatic stress disorder (PTSD) or experience suicidal thoughts than service members who don't have insomnia before they deploy, a U.S. study suggests.
Poor sleep may be linked to a greater risk for poor mental health on college campuses, new research suggests. With each night of insufficient sleep, the risk of mental health symptoms increased by roughly 20%.
NEW YORK—Cognitive-behavioral therapy (CBT) delivered by video call appears to inspire as much confidence among patients with insomnia as does the traditional face-to-face approach, according to preliminary research.